MICROTECH MED-B: (1) 2023 ANNUAL REPORT; (2) 2023 BOARD AND SUPERVISORY COMMITTEE WORK REPORTS; (3) FINAL ACCOUNT REPORT FOR 2023; (4) PROPOSED 2023 PROFIT DISTRIBUTION PLAN; (5) 2023 INDEPENDENT NON-EXECUTIVE DIRECTORS WORK REPORT; (6) PROPOSED RE-APPOINTMENT OF AUDITOR F
MICROTECH MED-B: (1) APPOINTMENT OF JOINT COMPANY SECRETARY; WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES; AND (2) PROPOSED REDUCTION OF THE REGISTERED CAPITAL AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
MICROTECH MED-B: COMPLETION OF THE H SHARE FULL CIRCULATION PROGRAM
MICROTECH MED-B: THE 2023 H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE
MICROTECH MED-B: COMPLETION OF THE H SHARE FULL CIRCULATION PROGRAM
MICROTECH MED-B: THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE
MICROTECH MED-B: (1) 2021 ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2021... (9) GENERAL MANDATE TO ISSUE SHARES; (10) GENERAL MANDATE TO REPURCHASE H SHARES; (11) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (12) PROPOSED ADOPTION OF THE 20
MICROTECH MED-B: GREEN APPLICATION FORM
MICROTECH MED-B: GLOBAL OFFERING
No Data